| Identification | Back Directory | [Name]
V-PYRRO/NO | [CAS]
179344-98-0 | [Synonyms]
V-PYRRO/NO
PYRRO NONOATE
1-[(ETHENYLOXY)-NNO-AZOXY]-PYRROLIDINE
V-PYRRO/NO, 1-[(ethenyloxy)-NNO-azoxy]-pyrrolidine
O2-VINYL 1-(PYRROLIDIN-1-YL)DIAZEN-1-IUM-1,2-DIOLATE
O2-VINYL 1-(PYRROLIDIN-1-YL)DIAZEN-1-UIM-1,2-DIOLATE
1-(Ethenyloxy)-3-(2-pyrrolidinyl)-3-(5-pyrrolidinyl)-
1-(Ethenyloxy)-3-(2-pyrrolidinyl)-3-(5-pyrrolidinyl)-1-triazenamine 2-oxide
1-[(Ethenyloxy)-NNO-azoxy]-pyrrolidine, O2-Vinyl-1-(pyrrolidin-1-yl)diazen-1-uim-1,2-diolate | [Molecular Formula]
C6H11N3O2 | [MDL Number]
MFCD06407925 | [MOL File]
179344-98-0.mol | [Molecular Weight]
157.17 |
| Chemical Properties | Back Directory | [Appearance]
Pale Yellow Oil | [Fp ]
14 °C | [storage temp. ]
−20°C
| [solubility ]
Ethanol | [form ]
Pale yellow oil. | [color ]
Pale Yellow | [Stability:]
Store in Freezer (> 1 year at -20°) |
| Hazard Information | Back Directory | [Chemical Properties]
Pale Yellow Oil | [Uses]
V-PYRRO/NO is a metabolically activated nitric oxide (NO) donor drug that can be used to selectively target NO delivery to the liver. The compound is metabolized by the liver, and spontaneously decom
poses with a half-life of 3 seconds, liberating NO. Infusion of 30nmol/kg of V-PYRRO/NO in rats causes only a slight drop in blood pressure. At concentrations >100ug, V-PYRRO/NO increases hepatocyte
viability against TNF-a-induced apoptosis by approximately 2-fold compared to cells not treated with this compound. |
|
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Website: |
http://www.energy-chemical.com |
| Company Name: |
MOLEKULA Ltd.
|
| Tel: |
+44 (0) 1747 831066 |
| Website: |
www.molekula.co.uk |
| Company Name: |
Medical Isotopes
|
| Tel: |
1-(603) 635-1722 |
| Website: |
www.medicalisotopes.com |
| Company Name: |
SIGMA-RBI
|
| Tel: |
800 736 3690 (Orders) |
| Website: |
www.sigma-aldrich.com |
|